[Use of synthetic peptides as additional antigens for detecting antibodies to hepatitis C virus]. 1998

Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev

Peptide fragments of hepatitis C virus (HCV) nonstructural protein NS4 capable of reacting with anti-HCV in enzyme immunoassay are synthesized. Addition of synthetic peptides to recombinant nucleocapsid HCV antigen absorbed on solid phase notably improves the efficacy of detection of antibodies to HCV in the sera of patients with hepatitis C.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D017361 Viral Nonstructural Proteins Proteins encoded by a VIRAL GENOME that are not structural components of VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY. Nonstructural Proteins, Viral,NS Proteins, Viral,Viral NS Proteins,Viral Non-Structural Proteins,Viral Nonstructural Protein,Viral Nonstructural Proteins NS1,Viral Nonstructural Proteins NS2,Nonstructural Protein, Viral,Viral Non Structural Proteins
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
April 1993, Journal of hepatology,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
January 2006, Biochemical and biophysical research communications,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
January 2002, Voprosy virusologii,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
April 1993, Journal of clinical microbiology,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
May 1981, Tropical animal health and production,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
January 1986, Ciba Foundation symposium,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
January 1996, Voprosy virusologii,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
July 2013, Expert opinion on investigational drugs,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
January 1996, East African medical journal,
Iu A Semiletov, and T V Firsova, and I V Kruglov, and T I Alekseenkova, and N V Petrakova, and T I Kalinina, and V A Shibnev
December 1991, Scandinavian journal of gastroenterology,
Copied contents to your clipboard!